With manufacturing facilities in Israel and Germany, and eight offices around the world, Camtek provides state of the art solutions in line with customers' requirements.
This press release is available at http://www.camtek.com
This press release contains statements that may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on Camtek's current beliefs, expectations and assumptions about its business and industry, all of which may change. Forward-looking statements can be identified by the use of words including "believe," "anticipate," "should," "intend," "plan," "will," "may," "expect," "estimate," "project," "positioned," "strategy," and similar expressions that are intended to identify forward-looking statements, including statements relating to the compound semiconductors market and our position in this market and the anticipated timing of delivery of the systems. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of Camtek to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause our actual results to differ materially from those contained in the forward-looking statements include, but are not limited to the effects of the evolving nature of the war situation in Israel, and the related evolving regional conflicts; the continued demand for HPC, HBM and Chiplet devices resulting from, among other things, the field of AI surging worldwide across companies, industries and nations; our dependency upon the semiconductor industry and the risk that unfavorable economic conditions or low capital expenditures may negatively impact our operating results; formal or informal imposition by countries of new or revised export and/or import and doing-business regulations or sanctions, including but not limited to changes in U.S. trade policies, changes or uncertainty related to the U.S. government entity list and changes in the ability to sell products incorporating U.S originated technology, which can be made without prior notice, and our ability to effectively address such global trade issues and changes; the risks relating to the concentration of a significant portion of our business in certain countries in the Asia Pacific Region, particularly China, Taiwan and Korea, some of which might be subject to the trade restrictions referred to above or involved in trade wars with countries which might impose such trade restrictions; changing industry and market trends; and those other factors discussed in our Annual Report on Form 20-F as published on March 21, 2024, as well as other documents that may be subsequently filed by Camtek from time to time with the Securities and Exchange Commission. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Camtek does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release unless required by law.
While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Camtek's views only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. Camtek does not assume any obligation to update any forward-looking statements unless required by law.
This press release provides financial measures that exclude: (i) share based compensation expenses; and (ii) acquisition related expenses and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it is important to make these non-GAAP adjustments available to investors. A reconciliation between the GAAP and non-GAAP results appears in the tables at the end of this press release. The results reported in this press-release are preliminary unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.
Consolidated Balance Sheets | |||||||||
(In thousands) | |||||||||
|
|
|
| ||||||
| September 30, |
| December 31, | ||||||
| 2024 |
| 2023 | ||||||
| U.S. Dollars | ||||||||
Assets |
|
| |||||||
|
|
| |||||||
Current assets |
|
|
| ||||||
Cash and cash equivalents | 99,292 |
| 119,968 | ||||||
Short-term deposits | 273,350 |
| 215,250 | ||||||
Marketable securities | 26,839 |
| 18,816 | ||||||
Trade accounts receivable, net | 70,749 |
| 87,300 | ||||||
Inventories | 104,941 |
| 85,905 | ||||||
Other current assets | 25,049 |
| 19,548 | ||||||
|
|
|
| ||||||
Total current assets | 600,220 |
| 546,787 | ||||||
|
|
|
| ||||||
|
|
|
| ||||||
|
|
|
| ||||||
Long-term deposits | 6,000 |
| 21,000 | ||||||
Marketable securities | 83,188 |
| 73,576 | ||||||
Long-term inventory | 11,309 |
| 9,023 | ||||||
Deferred tax asset, net | 2,642 |
| 2,642 | ||||||
Other assets, net | 2,034 |
| 1,370 | ||||||
Property, plant and equipment, net | 47,418 |
| 41,987 | ||||||
Intangible assets, net | 14,258 |
| 16,937 | ||||||
Goodwill | 74,345 |
| 74,345 | ||||||
|
|
|
| ||||||
Total non- current assets | 241,194 |
| 240,880 | ||||||
|
|
|
| ||||||
Total assets | 841,414 |
| 787,667 | ||||||
|
|
| |||||||
Liabilities and shareholders' equity |
|
| |||||||
|
|
| |||||||
Current liabilities |
|
| |||||||
Trade accounts payable | 44,160 |
| 42,187 | ||||||
Other current liabilities | 69,451 |
| 54,487 | ||||||
|
|
|
| ||||||
Total current liabilities | 113,611 |
| 96,674 | ||||||
|
|
|
| ||||||
Long-term liabilities |
|
|
| ||||||
Deferred tax liabilities, net | 5,388 |
| 7,541 | ||||||
Other long-term liabilities | 10,911 |
| 10,473 | ||||||
Convertible notes | 197,651 |
| 196,831 | ||||||
| 213,950 |
| 214,845 | ||||||
|
|
|
| ||||||
Total liabilities | 327,561 |
| 311,519 | ||||||
|
|
|
| ||||||
|
|
|
| ||||||
|
|
|
| ||||||
Shareholders' equity |
|
|
| ||||||
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at
|
|
|
| ||||||
47,480,007 issued shares at September 30, 2024 and 46,993,998 at
|
|
|
| ||||||
45,387,631 shares outstanding at September 30, 2024 and 44,901,622 at
|
177 |
|
176 | ||||||
Additional paid-in capital | 211,229 |
| 200,389 | ||||||
Accumulated other comprehensive income (loss) | 1,532 |
| 129 | ||||||
Retained earnings | 302,813 |
| 277,352 | ||||||
| 515,751 |
| 478,046 | ||||||
Treasury stock, at cost (2,092,376 shares as of September 30, 2024 and
|
(1,898) |
|
(1,898) | ||||||
|
|
|
| ||||||
Total shareholders' equity | 513,853 |
| 476,148 | ||||||
|
|
|
| ||||||
Total liabilities and shareholders' equity | 841,414 |
| 787,667 | ||||||
|
|
|
|